RSS

News

Preclinical Research on BPC-157: Insights from 2025 Systematic Reviews on Musculoskeletal Healing

Preclinical Research on BPC-157: Insights from 2025 Systematic Reviews on Musculoskeletal Healing

Monday, January 19, 2026

Summary of recent preclinical animal studies exploring BPC-157's effects on tendon, ligament, muscle, and bone repair models. Educational overview only – research use only.

Read More
Peptide Purity and Analytical Testing Methods in Research Settings

Peptide Purity and Analytical Testing Methods in Research Settings

Sunday, January 18, 2026

Overview of common laboratory techniques used to verify purity of research peptides (HPLC, mass spectrometry). Educational summary only.

Read More
2026 FDA Predictions: Potential Shifts on Peptides & RFK Jr.'s Influence

2026 FDA Predictions: Potential Shifts on Peptides & RFK Jr.'s Influence

Friday, January 16, 2026

Professor Paul Knoepfler predicts easier peptide compounding in 2026 driven by RFK Jr., amid risks and limited data on many unproven peptides. Educational summary of public regulatory analysis.

Read More

All peptide products offered by Sumrday, LLC are sold for research, laboratory, or analytical purposes only and are not intended for human or animal consumption.

Statements on this website have not been evaluated by the U.S. Food and Drug Administration. Products are not intended to diagnose, treat, cure, or prevent any disease.

Sumrday, LLC is a product supplier and is not a compounding pharmacy or outsourcing facility as defined under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act.